[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 8, 2000

Treatment for Opioid DependenceQuality and Access

Author Affiliations

Author Affiliations: Department of Psychiatry, Yale University School of Medicine, New Haven, and Veterans Affairs Healthcare Systems, West Haven, Conn.

JAMA. 2000;283(10):1337-1339. doi:10.1001/jama.283.10.1337

A major priority in US medicine is the need to improve quality and access while containing costs. Two articles in this issue of THE JOURNAL address 2 important quality and access issues in opioid stabilization treatment: primary care methadone treatment,1 which can improve access by broadening the prescriber base, and the abbreviation of methadone therapy,2 which might improve access by allowing more patients per year in the available treatment slots. These articles address 2 strategies to enhance quality: directly observed methadone administration in primary care and intensified counseling in brief methadone treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview